ABBREV. |
ABBREVIATED TERM or PHRASE |
| 2,3-DPG
|
2,3-dishospyhoglycerate
|
| AABB |
American
Association of Blood Banks |
| ACT
|
Activated
Clotting Time |
| ADH
|
Antidiuretic
Hormone |
| AHG |
Antihuman
Globulin |
| AHTR |
Acute
Hemolytic Transfusion Reaction (also HTR) |
| AIDS
|
Acquired
Immune Deficiency Syndrome |
| ALT
|
Alanine
Aminotransferase |
| ANA |
Antinuclear
Antibody |
| ANH
|
Acute
Normovolemic Hemodilution |
| anti-HBc
|
Antibody
to Hepatitis B Core Antigen |
| anti-HCV
|
Antibody
to Hepatitis C Virus |
| anti-HTLV-I/II |
Antibody
to Human T-cell Lymphotropic Virus type I/II |
| aPPT
|
Activated
Partial Thromboplastin Time |
| ARDS
|
Acute
Respiratory Distress Syndrome |
| AST
|
Aspartate
Transaminase |
| ATIII
|
Antithrombin
III |
| CHD |
Coronary
Heart Disease |
| CJD |
Creutzfeldt-Jakob
Disease (see nvCJD) |
| CMV
|
Cytomegalovirus
|
| CPD
|
Citrate,
Phosphate, Dextrose (solution) |
| CPDA-1
|
Citrate,
Phosphate, Dextrose-Adenine (solution) |
| C/T
|
Crossmatch-to-Transfusion
ratio (C:T) |
| DDAVP
|
1-Desamino-8-D-Arginine
Vasopressin (desmopressin) |
| DIC
|
Disseminated
Intravascular Coagulopathy |
| EACA
|
Epsilon-Aminocaproic
Acid |
| FDA
|
Food and
Drug Administration |
| FFP
|
Fresh
Frozen Plasma |
| FNHTR
|
Febrile
Nonhemolytic Transfusion Reaction |
| GGTP
|
Gamma
Glutamyl Transferase (GGT) |
| GHVD |
Graft-Versus-Host
Disease |
| HAM
|
HTLV-I-Associated
Myelopathy |
| HBOC
|
Hemoglobin-Based
Oxygen Carrier |
| HBsAg
|
Hepatitis
B Surface Antigen |
| HB
|
Hemoglobin
|
| HCT
|
Hematocrit
|
| HBV
|
Hepatitis
B Virus |
| HCV
|
Hepatitis
C Virus |
| HDN |
Hemolytic
Disease of the Newborn |
| HES
|
Hydroxyethyl
Starch |
| HH
|
Hemochromatosis
|
| HIV
|
Human
Immunodeficiency Virus |
| HLA
|
Human
Leukocyte Antigen |
| HTLV-I/II |
Human
T-cell Lymphotropic Virus type I/II |
| HTR
|
Hemolytic
Transfusion Reaction (also AHTR) |
| IAD |
Intraoperative
Autologous Donation |
| IFG |
Impaired
Fasting Glucose |
| IgA
|
Immunoglobulin
A |
| ITP |
Idiopathic
Thrombocytopenic Purpura |
| LD |
Lactate
Dehydrognase |
| MAC |
Mycobacterium
Avium Complex |
| MCH |
Mean
Corpuscular Hemoglobin |
| MCHC |
Mean
Corpuscular Hemoglobin Concentrate |
| MCV |
Mean
Corpuscular Volume |
| mg/dL |
milligrams
per deciliter |
| MPV
|
Mean
Platelet Volume |
| NAT
|
Nucleic
Acid Amplification Testing |
| nvCJD |
New
Variation Creutzfeldt-Jakob Disease (nCJD) |
| PABD |
Preoperative
Autologous Blood Donation |
| PAT |
Preoperative
Autologous Blood Transfusion |
| PFC
|
Perflurochemical(s)
|
| PLTs |
Platlets |
| PMNs |
Polymorphonuclear
Leukocytes |
| PPF
|
Purified
Protein Fraction |
| PRP
|
Platelet-Rich
Plasma |
| PT
|
Prothrombin
Time |
| PTP
|
Posttransfusion
Purpura |
| PTT
|
Partial
Thromboplastin Time |
| Q-T
|
from QRS
complex to end of T wave (interval) |
| RBCs |
Red Blood
Cells |
| Rh |
Rhesus
Factor |
| STS
|
Serological
Test for Syphilis |
| T&S
|
Type and
Screen |
| TA-GVHD |
Transfusion-Associated
Graft-Versus-Host Disease |
| TEG
|
Thromboelastograph
|
| TRALI
|
Transfusion-Related
Acute Lung Injury |
| TSH |
Thyroid
Stimulating Hormone |
| TSP
|
Tropical
Spastic Paraparesis |
| TSE |
Transmissible
Spongiform Encephalopathies |
| TTP |
Thrombotic
Thrombocytopenic Purpura |
| TTTS
|
Twin to
Twin Transfusion Syndrome |
| TXA
|
Transexamic
Acid |
| WBCs |
White
Blood Cells |
| vWd
|
von
Willebrand's Disease |
| vWf
|
von
Willebrand's Factor |
